Nasdaq

Tactile Medical Presents Promising Clinical Data for Flexitouch Plus in Treating Head and Neck Cancer-Related Lymphedema at ASCO 2025 Annual Meeting

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...
Business Insider

Tactile Medical Expands Launch of Nimbl™ to Include Patients with Lower Extremity Lymphedema

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...
Business Wire

Medicare Policy Change Will Significantly Reduce Treatment Options for Cancer Patients and Others with Lymphedema, Says Tactile Medical

MINNEAPOLIS--(BUSINESS WIRE)--Despite convincing clinical evidence on the health and economic benefits of home therapy, Medicare has proposed a policy that will severely restrict reimbursement for ...
Nasdaq

The Future of Medical Devices: Two Strong Buys You Can't Miss

Tactile Systems Technology (NASDAQ: TCMD) was founded in 1995 and is a medical technology company focused on developing and marketing at-home therapies for people with chronic disorders, including ...